[{"id":"e5f2912b-4e70-4d16-a5ef-71f099ef4b42","acronym":"","url":"https://clinicaltrials.gov/study/NCT00391118","created_at":"2021-01-18T01:21:52.062Z","updated_at":"2024-07-02T16:36:39.969Z","phase":"Phase 2","brief_title":"Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo (\"Sugar Pill\")","source_id_and_acronym":"NCT00391118","lead_sponsor":"Eli Lilly and Company","biomarkers":" PTEN • MUC16 • GSK3B • PRKCB","pipe":"","alterations":" ","tags":["PTEN • MUC16 • GSK3B • PRKCB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • paclitaxel • Kinenza (enzastaurin)"],"overall_status":"Completed","enrollment":" Enrollment 153","initiation":"Initiation: 11/01/2006","start_date":" 11/01/2006","primary_txt":" Primary completion: 04/01/2010","primary_completion_date":" 04/01/2010","study_txt":" Completion: 07/01/2012","study_completion_date":" 07/01/2012","last_update_posted":"2020-10-19"},{"id":"2b886b25-d61f-4bf9-beb7-aaace50b841c","acronym":"","url":"https://clinicaltrials.gov/study/NCT00042666","created_at":"2021-06-23T22:52:32.202Z","updated_at":"2024-07-02T16:36:42.179Z","phase":"Phase 2","brief_title":"A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.","source_id_and_acronym":"NCT00042666","lead_sponsor":"Eli Lilly and Company","biomarkers":" PRKCB","pipe":"","alterations":" ","tags":["PRKCB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Kinenza (enzastaurin)"],"overall_status":"Completed","enrollment":" Enrollment 55","initiation":"Initiation: 06/01/2002","start_date":" 06/01/2002","primary_txt":" Primary completion: 09/01/2008","primary_completion_date":" 09/01/2008","study_txt":" Completion: 09/01/2008","study_completion_date":" 09/01/2008","last_update_posted":"2020-08-10"},{"id":"370e6b2e-796f-4e1b-a0c3-f76e727397f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT00436280","created_at":"2021-01-18T01:32:22.047Z","updated_at":"2024-07-02T16:36:42.265Z","phase":"Phase 2","brief_title":"Chemotherapy for Participants With Lymphoma","source_id_and_acronym":"NCT00436280","lead_sponsor":"Eli Lilly and Company","biomarkers":" CD20 • PRKCH • PRKCB","pipe":"","alterations":" ","tags":["CD20 • PRKCH • PRKCB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e gemcitabine • Rituxan (rituximab) • oxaliplatin • Kinenza (enzastaurin)"],"overall_status":"Completed","enrollment":" Enrollment 68","initiation":"Initiation: 02/01/2007","start_date":" 02/01/2007","primary_txt":" Primary completion: 11/01/2009","primary_completion_date":" 11/01/2009","study_txt":" Completion: 11/01/2012","study_completion_date":" 11/01/2012","last_update_posted":"2020-08-06"},{"id":"0a7b2fa7-a40c-474b-8236-37798e0d2949","acronym":"","url":"https://clinicaltrials.gov/study/NCT00088205","created_at":"2021-01-18T00:15:39.042Z","updated_at":"2024-07-02T16:36:43.664Z","phase":"Phase 2","brief_title":"Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma","source_id_and_acronym":"NCT00088205","lead_sponsor":"Eli Lilly and Company","biomarkers":" PRKCH • PRKCB","pipe":"","alterations":" ","tags":["PRKCH • PRKCB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Kinenza (enzastaurin)"],"overall_status":"Completed","enrollment":" Enrollment 60","initiation":"Initiation: 03/01/2004","start_date":" 03/01/2004","primary_txt":" Primary completion: 05/01/2008","primary_completion_date":" 05/01/2008","study_txt":" Completion: 05/01/2008","study_completion_date":" 05/01/2008","last_update_posted":"2020-07-01"},{"id":"6462b1e0-4b1c-4573-96bc-10fc5acd50bb","acronym":"","url":"https://clinicaltrials.gov/study/NCT00332202","created_at":"2021-06-23T22:52:36.234Z","updated_at":"2024-07-02T16:37:07.092Z","phase":"Phase 3","brief_title":"PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin","source_id_and_acronym":"NCT00332202","lead_sponsor":"Eli Lilly and Company","biomarkers":" PRKCB • EFS","pipe":"","alterations":" ","tags":["PRKCB • EFS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Kinenza (enzastaurin)"],"overall_status":"Completed","enrollment":" Enrollment 758","initiation":"Initiation: 06/01/2006","start_date":" 06/01/2006","primary_txt":" Primary completion: 04/01/2013","primary_completion_date":" 04/01/2013","study_txt":" Completion: 07/01/2013","study_completion_date":" 07/01/2013","last_update_posted":"2018-09-10"}]